Pulse Biosciences Q2 EPS $(0.36), Inline, Sales $434.000K Miss $533.333K Estimate
Benzinga Newsdesk 2 months ago
NewsEarningsEarnings Misses
Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.36) per share which met the analyst consensus estimate. This is a 28.57 percent decrease over losses of $(0.28) per share from the same period last year.
Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.36) per share which met the analyst consensus estimate. This is a 28.57 percent decrease over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $434.000 thousand which missed the analyst consensus estimate of $533.333 thousand by 18.62 percent.